News

Introducing the IHE Leader Series

Introducing the IHE Leader Series – A new on-line video series of Canadian and international expertise, on issues that impact Canadians.

Episode 1: Michele Evans, Assistant Deputy Minister, Pharmaceuticals and Supplementary Benefits Division, Alberta Health

Subject: Michele Evans explores questions such as the impact biosimilars has on government spending, the opportunities that Biosimilars could address, and asks the question what considerations should be made in their uptake and opens up the discussion on how biosimilars can be introduced into the Canadian market place. A new topic will be explored with every IHE Leaders Series release.


IHE Leaders Series Episode 1

“Biosimilars have had significant uptake and success in the European market, and in Canada we want to understand how we can do that in a way that’s acceptable and meets the needs of our clinicians and patients”
~ Michele Evans, Assistant Deputy Minister, Pharmaceuticals and Supplementary Benefits Division, Alberta Health

Our first video focuses on the timely subject of biosimilars, which is a major campaign of the IHE Life Sciences Open Innovation Platform™. To learn more, click HERE.

SHARE your ideas NOW! Impact Policy. Join the IHE Life Sciences Open Innovation Platform™.

The Institute of Health Economics (IHE) has recently launched the IHE Life Sciences Open Innovation Platform™, an online crowdsourcing or “ideasourcing” tool used to solve complex health policy challenges through the broad engagement of a wide range of stakeholders.

The current Campaigns on the Platform address the topic of biosimilars. Additional near-term campaigns are in development in the area of Real World Evidence.


How it Works:

REGISTER HERE

Then logon and:

  • SHARE your ideas - Post early and often to give time for others to comment and contribute.
  • VOTE and/or ADD to the ideas of others.
  • REPEAT – Check back often as the platform is ALIVE, with new comments and ideas every day.

Want to stay in the loop? Subscribe to IHE.